SEARCH

SEARCH BY CITATION

References

  • 1
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556562.MEDLINE
  • 2
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671675.MEDLINE
  • 3
    Seaberg EC, Belle SH, Beringer KC, Schivins JL, Detre KM. Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS liver transplant registry. In: CeckaJM, TerasakiPI, eds. Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 1737.
  • 4
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317322.MEDLINE
  • 5
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815820.MEDLINE
  • 6
    Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:4152.MEDLINE
  • 7
    Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 2000; 343:16661672.MEDLINE
  • 8
    Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358:958965.MEDLINE
  • 9
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26:500504.MEDLINE
  • 10
    Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 2001; 7:863869.MEDLINE
  • 11
    Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289293.MEDLINE
  • 12
    Anonymous. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25:658663.MEDLINE
  • 13
    Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:773779.MEDLINE
  • 14
    McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19(Suppl 1):5765.MEDLINE
  • 15
    Thierry P, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling M-H, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122:13031313.MEDLINE
  • 16
    Jain AB, Kashyap RS, Eghtesad B, Shakil O, Venkataraman R, Khan A, et al. Ribavirin dose adjustment in relation to renal function is mandatory for treatment of recurrent HCV infection in post liver transplant patients [Abstract]. Hepatology 2001; 34:409A.